HCA Healthcare (NYSE:HCA) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Thursday.
Other analysts have also recently issued reports about the stock. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Mizuho began coverage on shares of HCA Healthcare in a report on Friday, March 23rd. They set a “buy” rating and a $115.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $105.95.
NYSE HCA traded down $1.09 during trading hours on Thursday, reaching $103.09. 1,631,546 shares of the company traded hands, compared to its average volume of 2,032,772. HCA Healthcare has a 12 month low of $71.18 and a 12 month high of $108.85. The company has a debt-to-equity ratio of -7.13, a current ratio of 1.39 and a quick ratio of 1.17. The company has a market capitalization of $36.80 billion, a price-to-earnings ratio of 15.64, a price-to-earnings-growth ratio of 1.03 and a beta of 0.51.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, May 1st. The company reported $2.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.07 by $0.26. The company had revenue of $11.42 billion for the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a net margin of 5.96% and a negative return on equity of 55.50%. The firm’s revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.74 earnings per share. analysts anticipate that HCA Healthcare will post 8.83 EPS for the current year.
In related news, insider Jonathan B. Perlin sold 12,500 shares of the stock in a transaction dated Thursday, June 21st. The shares were sold at an average price of $108.00, for a total value of $1,350,000.00. Following the sale, the insider now owns 107,894 shares of the company’s stock, valued at approximately $11,652,552. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Jonathan B. Perlin sold 25,000 shares of the stock in a transaction dated Monday, June 11th. The stock was sold at an average price of $106.00, for a total transaction of $2,650,000.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,974 shares of company stock worth $5,511,523. Corporate insiders own 2.80% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. We Are One Seven LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $110,000. Summit Trail Advisors LLC increased its stake in HCA Healthcare by 9,933.3% during the 1st quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock valued at $113,000 after buying an additional 111,650 shares during the period. Parallel Advisors LLC increased its stake in HCA Healthcare by 76.2% during the 4th quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after buying an additional 578 shares during the period. Salem Investment Counselors Inc. acquired a new position in HCA Healthcare during the 4th quarter valued at about $130,000. Finally, Verition Fund Management LLC acquired a new position in HCA Healthcare during the 4th quarter valued at about $205,000. 70.33% of the stock is currently owned by institutional investors and hedge funds.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.